My Portfolio
+
LINK YOUR PORTFOLIO

Cytokinetics Inc CYTK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
70.71UNCH (UNCH)
Volume
66,844
Close
70.71quote price arrow down-0.20 (-0.28%)
Volume
1,523,893
52 week range
30.81 - 80.20
Loading...
  • Open70.65
  • Day High72.00
  • Day Low70.17
  • Prev Close70.91
  • 52 Week High80.20
  • 52 Week High Date05/05/26
  • 52 Week Low30.81
  • 52 Week Low Date06/03/25

Key Stats

  • Market Cap9.587B
  • Shares Out135.58M
  • 10 Day Average Volume1.79M
  • Dividend-
  • Dividend Yield-
  • Beta0.44

KEY STATS

  • Open70.65
  • Day High72.00
  • Day Low70.17
  • Prev Close70.91
  • 52 Week High80.20
  • 52 Week High Date05/05/26
  • 52 Week Low30.81
  • 52 Week Low Date06/03/25
  • Market Cap9.587B
  • Shares Out135.58M
  • 10 Day Average Volume1.79M
  • Dividend-
  • Dividend Yield-
  • Beta0.44

RATIOS/PROFITABILITY

  • EPS (TTM)-6.84
  • P/E (TTM)-10.33
  • Fwd P/E (NTM)-11.45
  • EBITDA (TTM)-629.042M
  • ROE (TTM)-572.15%
  • Revenue (TTM)105.815M
  • Gross Margin (TTM)15.88%
  • Net Margin (TTM)-784.02%
  • Debt To Equity (MRQ)-140.65%

EVENTS

  • Earnings Date08/05/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Cytokinetics, Incorporated is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing muscle biology-directed drug candidates as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The Company is engaged in the commercialization of aficamten, a cardiac myosin inhibitor, and is being evaluated in additional clinical trials enrolling patients with obstructive and...
John Henderson
Independent Chairman of the Board
Robert Blum
President, Chief Executive Officer, Director
Sung Lee
Chief Financial Officer, Executive Vice President
Jeffrey Hessekiel J.D.
Executive Vice President, Chief Legal and Administrative Officer
Fady Malik M.D., Ph.D.
Executive Vice President - Research and Development
Address
350 Oyster Point Boulevard
South San Francisco, CA
94080
United States